Ontology highlight
ABSTRACT: This a model from the article: This model was taken from the CellML repository and automatically converted to SBML. This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2011 The BioModels.net Team. In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not..
Modeling defective interfering virus therapy for AIDS: conditions for DIVsurvival.
Nelson GW, Perelson AS. Math Biosci 1995 Feb;125(2):127-53 7881191 ,
Abstract:
The administration of a genetically engineered defective interfering virus (DIV)that interferes with HIV-1 replication has been proposed as a therapy for HIV-1infection and AIDS. The proposed interfering virus, which is designed tosuperinfect HIV-1 infected cells, carries ribozymes that cleave conservedregions in HIV-1 RNA that code for the viral envelope protein. Thus DIVinfection of HIV-1 infected cells should reduce or eliminate viral production bythese cells. The success of this therapeutic strategy will depend both on theintercellular interaction of DIV and HIV-1, and on the overall dynamics of virusand T cells in the body. To study these dynamical issues, we have constructed amathematical model of the interaction of HIV-1, DIV, and CD4+ cells in vivo. Theresults of both mathematical analysis and numerical simulation indicate thatsurvival of the engineered DIV purely on a peripheral blood HIV-1 infection isunlikely. However, analytical results indicate that DIV might well survive onHIV-1 infected CD4+ cells in lymphoid organs such as lymph nodes and spleen, oron other HIV-1 infected cells in these organs.
The original model was: Nelson GW, Perelson AS. (1995) - version=1.0
The original CellML model was created by:
Ethan Choi
mcho099@aucklanduni.ac.nz
The University of Auckland
To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.
ORGANISM(S): Homo sapiens
SUBMITTER: Camille Laibe
PROVIDER: MODEL1006230033 | biostudies-other |
SECONDARY ACCESSION(S): 7881191
REPOSITORIES: biostudies-other

Mathematical biosciences 19950201 2
The administration of a genetically engineered defective interfering virus (DIV) that interferes with HIV-1 replication has been proposed as a therapy for HIV-1 infection and AIDS. The proposed interfering virus, which is designed to superinfect HIV-1 infected cells, carries ribozymes that cleave conserved regions in HIV-1 RNA that code for the viral envelope protein. Thus DIV infection of HIV-1 infected cells should reduce or eliminate viral production by these cells. The success of this therap ...[more]